EUVIMEDEUVIMED entdecken
Crossref

Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors

Ebtehal M Husseiny iD, Hamada S Abulkhair iD, Sanadelaslam Sa El-Hddad, Nada Osama, Mona S El-Zoghbi iD

Future Medicinal Chemistry · 2023

DOI: 10.4155/fmc-2023-0139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2023. Verfasst von Ebtehal M Husseiny und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo, 11754, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsHumansCell Line, TumorBenzimidazolesMCF-7 CellsDrug DesignDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureCyclin-Dependent Kinase 9

Stichwörter der Autor:innen

CDK9aminopyridoneapoptosisbenzimidazolecancercell cycledockingdrug discoveryfragment-based designsynthesis

Substanzen

Antineoplastic AgentsBenzimidazolesCDK9 protein, humanCyclin-Dependent Kinase 9

Autor:innen und Institutionen

  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo, 11754, Egypt.
  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, 11884, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Horus University - Egypt, New Damietta, 34518, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Omar Almukhtar University, Al Bayda, 102345, Libya.
  • Biochemistry Department, Faculty of Pharmacy, Menoufia University, Shibin Elkom, Menoufia, 32511, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Menoufia University, Shebin El-Koum, 32511, Egypt.

ORCID-Profile: Ebtehal M Husseiny, Hamada S Abulkhair, Mona S El-Zoghbi

Zitieren

APA

Husseiny, E. M., Abulkhair, H. S., El-Hddad, S. S., Osama, N., & El-Zoghbi, M. S. (2023). Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0139

Vancouver

Husseiny EM, Abulkhair HS, El-Hddad SS, Osama N, El-Zoghbi MS. Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors. Future Medicinal Chemistry. 2023. doi:10.4155/fmc-2023-0139

BibTeX
@article{Husseiny2023,
  author = {Husseiny, Ebtehal M and Abulkhair, Hamada S and El-Hddad, Sanadelaslam Sa and Osama, Nada and El-Zoghbi, Mona S},
  title = {Aminopyridone-Linked Benzimidazoles: A Fragment-Based Drug Design for the Development of CDK9 Inhibitors},
  journal = {Future Medicinal Chemistry},
  year = {2023},
  doi = {10.4155/fmc-2023-0139}
}
Kostenlos starten →